EMA Warns of Major Staff Losses, Delayed Drug Approvals in HQ Relocation

Published: Sep 27, 2017

The European Medicines Agency (EMA) on Tuesday warned that it could lose a majority of its staff based on which of the 19 cities vying to host the medicines regulator is selected by the European Council in November.

Based on the results of a survey completed by 92% of EMA's staff earlier this month, the agency says it could lose between 19% and 94% of its staff depending on which city is selected as its future host.

"For certain locations staff retention rates could be significantly less than 30%. T

Back to news